STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3953 by analyst upside · 2026-08-13
MEDP
Medpace Holdings, Inc.
Healthcare · Market Cap $17B · P/E 35.6x
ANALYST PRICE TARGET
-2.5%
implied upside to consensus target
Current Price $596.98
Consensus Target $581.83
Bull Target $692.0
Bear Target $370.0
Analysts Covering 12
ANALYST CONSENSUS - HOLD
Strong Buy
1
Buy
1
Hold
9
Sell
1
52-Week Low $373.0
52-Week High $677.9
YTD Return +4.5%
FUNDAMENTALS
Market Cap $17B
P/E Ratio (TTM) 35.6x
Forward P/E 30.9x
EPS (TTM) $16.78
PEG Ratio 3.16
Dividend Yield N/A
Revenue (TTM) $2.8B
Profit Margin 17.7%
52-WEEK RANGE
52-Week Low $373.0
52-Week High $677.9
Current Price $596.98
Bear Target $370.0
Bull Target $692.0
● Now $596.98 ● Target $581.83
TRADING DATA
Avg Volume 327K
YTD Return +4.5%
Analyst Count 12
Consensus Hold
Upside to Target -2.5%
Last Updated 2026-08-13

ANALYST SUMMARY

Medpace Holdings, Inc. (MEDP) is currently trading at $596.98 with a Wall Street consensus price target of $581.83, which is 2.5% below the current price over the next 12 months. 12 analysts currently cover MEDP, with a consensus rating of Hold - 17% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $692.0, while the most cautious has a target of $370.0.

MEDP operates in the Healthcare sector with a market capitalisation of $17B. The stock is up 4.5% year-to-date and is currently trading near the upper end of its 52-week range of $373.0 – $677.9.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MEDP, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-04-24 Building track record
BMO Capital - Reiterated
Market Perform → Market Perform 2026-04-24 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-04-24 Building track record
Baird - Reiterated
Outperform → Outperform 2026-04-24 Building track record
Barclays ↑ Upgrade
Underweight → Equal-Weight 2026-03-06 Building track record
RBC Capital ● Initiated
Outperform 2026-03-03 Building track record
TD Cowen ↑ Upgrade
Sell → Hold 2026-02-18 Building track record
Jefferies ↑ Upgrade
Hold → Buy 2026-02-13 50% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
20/30
Consensus clarity
19/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →